ijo
www.spandidos-publications.com
Home  | About  | Contact
Spandidos Logo
Advanced Search
Login  | Register


congress_banner

main_table_top_image
   Current Issue Early Online Archive Manuscript Submission About Editor and Editorial Academy Sitemap
HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin

Authors:
Irina Svechnikova, Per M. Almqvist, Tomas J. Ekström

Affiliations:
Department of Woman and Child Health, Karolinska Institutet, Pediatric Endocrinology Unit, Q2:08, Karolinska University and Hospital, S-171 76, Stockholm, Sweden. irina.svechnikova@ki.se

Pages:
821-827

Abstract:

The anti-neoplastic effects of histone deacetylase inhibitors (HDACi), Trichostatin A (TSA) and 4-phenylbutyrate (4-PB) on the human glioblastoma cell lines GBM-29, U-343 MG and U-343 MGa Cl. 2:6 were investigated. TSA and 4-PB induced apoptosis in the three cell lines in a dose- and time-dependent manner. Whereas caspase-3 activation was detected in all three cell lines, U-343 MG cells were more sensitive to the apoptotic effect of HDACi compared with U-343 MGa Cl. 2:6. TSA and 4-PB induced differentiation in the three cell lines, each cell line developing unique phenotypic characteristics. During long-term treatment with a low dose of HDACi U-343 MGa Cl. 2:6 cells developed an astrocytic morphology with expression of glial fibrillary acidic protein (GFAP). GFAP-negative U-343 MG cells changed their morphology in response to HDACi and down-regulated their expression of vimentin. The nestin and vimentin positive GBM-29 cells also showed a morphological differentiation, while the expression of the two malignancy markers decreased. In summary, our results showed that these three glioblastoma cell lines display unique phenotypes and differentiation patterns in response to HDACi.

International Journal of Oncology

April 2008
Volume 32 Number 4


Viewing options: Sign up for eToc alerts
Recommend to Library

Share this article:




main_table_bottom_image